Effects of Serotonergic Medications on Locomotor Performance in Humans with Incomplete Spinal Cord Injury

Journal of Neurotrauma

Volumn 31, Issue 15, 2014, Pages 1334-1342

  Leech, Kristan A ^a,b   Kinnaird, Catherine R ^b   Hornby, T George ^a,b,c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b REHABILITATION INSTITUTE OF CHICAGO   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

locomotor function; neurotransmitters; rehabilitation; spinal cord injury

Indexed keywords

CYPROHEPTADINE; ESCITALOPRAM; CITALOPRAM; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANKLE; ANKLE DORSIFLEXION; ANKLE PLANTARFLEXION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROMYOGRAM; ELECTROMYOGRAPHY; GAIT; GASTROCNEMIUS MUSCLE; HAMSTRING; HIP; HIP EXTENSION; HIP FLEXION; HIP KNEE AVERAGE COEFFICIENT OF CORRELATION; HUMAN; INCOMPLETE SPINAL CORD INJURY; JOINT FUNCTION; KINEMATICS; KNEE; KNEE EXTENSION; KNEE FUNCTION; LOCOMOTION; MALE; MOBILIZATION; MUSCLE CONTRACTION; OXYGEN CONSUMPTION; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; RECTUS FEMORIS MUSCLE; SPINAL CORD INJURY; TIBIALIS ANTERIOR MUSCLE; TREADMILL; VASTUS LATERALIS MUSCLE; VELOCITY; CONVALESCENCE; DRUG EFFECTS; FEMALE; MIDDLE AGED; MOTOR ACTIVITY; SPINAL CORD INJURIES;

ADULT; CITALOPRAM; CYPROHEPTADINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; RECOVERY OF FUNCTION; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SPINAL CORD INJURIES;

EID: 84905659555     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.3206     Document Type: Article

References (63)

1. Li, X., Murray, K., Harvey, P.J., Ballou, E.W., and Bennett, D.J. (2007). Serotonin facilitates a persistent calcium current in moto-neurons of rats with and without chronic spinal cord injury. J. Neu-rophysiol. 97, 1236-1246.
2. Murray, K.C., Nakae, A., Stephens, M.J., Rank, M., D'Amico, J., Harvey, P.J., Li, X., Harris, R.L., Ballou, E.W., Anelli, R., Heckman, C.J., Mashimo, T., Vavrek, R., Sanelli, L., Gorassini, M.A., Bennett, D.J., and Fouad, K. (2010). Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors. Nat. Med. 16, 694-700.
3. Gorassini, M.A., Knash, M.E., Harvey, P.J., Bennett, D.J., and Yang, J.F. (2004). Role of motoneurons in the generation of muscle spasms after spinal cord injury. Brain 127, 2247-2258.
4. Lance, J. (1980). Symposium synopsis, in: Spasticity: Disordered Motor Control. Year Book Medical Publishers: Chicago, IL.
5. Katz, R.T., and Rymer, W.Z. (1989). Spastic hypertonia: mechanisms and measurement. Arch. Phys. Med. Rehabil. 70, 144-155.
6. Benz, E.N., Hornby, T.G., Bode, R.K., Scheidt, R.A., and Schmit, B.D. (2005). A physiologically based clinical measure for spastic reflexes in spinal cord injury. Arch. Phys. Med. Rehabil. 86, 52-59.
7. Little, J.W., Micklesen, P., Umlauf, R., and Britell, C. (1989). Lower extremity manifestations of spasticity in chronic spinal cord injury. Am. J. Phys. Med. Rehabil. 68, 32-36.
8. Scivoletto, G., Romanelli, A., Mariotti, A., Marinucci, D., Tamburella, F., Mammone, A., Cosentino, E., Sterzi, S., and Molinari, M. (2008). Clinical factors that affect walking level and performance in chronic spinal cord lesion patients. Spine 33, 259-264.
9. Krawetz, P., and Nance, P. (1996). Gait analysis of spinal cord injured subjects: effects of injury level and spasticity. Arch. Phys. Med. Re-habil. 77, 635-638.
10. Fung, J., and Barbeau, H. (1989). A dynamic EMG profile index to quantify muscular activation disorder in spastic paretic gait. Electro-encephalogr. Clin. Neurophysiol. 73, 233-244.
11. Saraf, P., Rafferty, M.R., Moore, J.L., Kahn, J.H., Hendron, K., Leech, K., and Hornby, T.G. (2010). Daily stepping in individuals with motor incomplete spinal cord injury. Phys. Ther. 90, 224-235.
12. Norton, B.J., Bomze, H.A., Sahrmann, S.A., and Eliasson, S.G. (1975). Correlation between gait speed and spasticity at the knee. Phys. Ther. 55, 355-359.
13. Gracies, J.M., Nance, P., Elovic, E., McGuire, J., and Simpson, D.M. (1997). Traditional pharmacological treatments for spasticity. Part II: general and regional treatments. Muscle Nerve Suppl. 6, S92-S120.
14. Taricco, M., Pagliacci, M.C., Telaro, E., and Adone, R. (2006). Pharmacological interventions for spasticity following spinal cord injury: results of a Cochrane systematic review. Eura. Medicophys. 42, 5-15.
15. Domingo, A., Al-Yahya, A.A., Asiri, Y., Eng, J.J., and Lam, T. (2012). A systematic review of the effects of pharmacological agents on walking function in people with spinal cord injury. J. Neurotrauma 29, 865-879.
16. Adams, M.M., and Hicks, A.L. (2005). Spasticity after spinal cord injury. Spinal Cord 43, 577-586.
17. Benarroch, E.E. (2012). GABAB receptors: structure, functions, and clinical implications. Neurology 78, 578-584.
18. Sieghart, W., and Sperk, G. (2002). Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr. Top. Med. Chem. 2, 795-816.
19. Sigel, E., and Steinmann, M.E. (2012). Structure, function, and modulation of GABA(A) receptors. J. Biol. Chem. 287, 40224-40231.
20. Burchiel, K.J., and Hsu, F.P. (2001). Pain and spasticity after spinal cord injury: mechanisms and treatment. Spine 26, S146-S160.
21. Francisco, G.E., and Boake, C. (2003). Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study. Arch. Phys. Med. Rehabil. 84, 1194-1199.
22. Wainberg, M., Barbeau, H., and Gauthier, S. (1990). The effects of cyproheptadine on locomotion and on spasticity in patients with spinal cord injuries. J. Neurol. Neurosurg. Psychiatry 53, 754-763.
23. Fung, J., Stewart, J.E., and Barbeau, H. (1990). The combined effects of clonidine and cyproheptadine with interactive training on the modulation of locomotion in spinal cord injured subjects. J. Neurol. Sci. 100, 85-93.
24. Norman, K.E., Pepin, A., and Barbeau, H. (1998). Effects of drugs on walking after spinal cord injury. Spinal Cord 36, 699-715.
25. Azouvi, P., Mane, M., Thiebaut, J.B., Denys, P., Remy-Neris, O., and Bussel, B. (1996). Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch. Phys. Med. Rehabil. 77, 35-39.
26. Wainberg, M., Barbeau, H., and Gauthier, S. (1986). Quantitative assessment of the effect of cyproheptadine on spastic paretic gait: a preliminary study. J. Neurol. 233, 311-314.
27. Barbeau, H., Richards, C.L., and Bedard, P.J. (1982). Action of cy-proheptadine in spastic paraparetic patients. J. Neurol. Neurosurg. Psychiatry 45, 923-926.
28. Thompson, C.K., and Hornby, T.G. (2013). Divergent modulation of clinical measures of volitional and reflexive motor behaviors following serotonergic medication in human incomplete spinal cord injury. J. Neurotrauma 30, 498-502.
29. Fouad, K., Rank, M.M., Vavrek, R., Murray, K.C., Sanelli, L., and Bennett, D.J. (2010). Locomotion after spinal cord injury depends on constitutive activity in serotonin receptors. J. Neurophysiol. 104, 2975-2984.
30. Edgerton, V.R., Tillakaratne, N.J., Bigbee, A.J., de Leon, R.D., and Roy, R.R. (2004). Plasticity of the spinal neural circuitry after injury. Annu. Rev. Neurosci. 27, 145-167.
31. Barbeau, H., Rossignol, S. (1990). The effects of serotonergic drugs on the locomotor pattern and on cutaneous reflexes of the adult chronic spinal cat. Brain Res. 514, 55-67.
32. Fong, A.J., Cai, L.L., Otoshi, C.K., Reinkensmeyer, D.J., Burdick, J.W., Roy, R.R., Edgerton, V.R. (2005). Spinal cord-transected mice learn to step in response to quipazine treatment and robotic training. J. Neurosci. 25, 11738-11747.
33. Antri, M., Orsal, D., and Barthe, J.Y. (2002). Locomotor recovery in the chronic spinal rat: effects of long-term treatment with a 5-HT2 agonist. Eur. J. Neurosci. 16, 467-476.
34. Stolp-Smith, K.A., and Wainberg, M.C. (1999). Antidepressant exacerbation of spasticity. Arch. Phys. Med. Rehabil. 80, 339-342.
35. Kim, CM., Eng, J.J., and Whittaker, M.W. (2004). Level walking and ambulatory capacity in persons with incomplete spinal cord injury: relationship with muscle strength. Spinal Cord 42, 156-162.
36. Dobkin, B., Barbeau, H., Deforge, D., Ditunno, J., Elashoff, R., Apple, D., Basso, M., Behrman, A., Harkema, S., Saulino, M., and Scott, M.; Spinal Cord Injury Locomotor Trial Group. (2007). The evolution of walking-related outcomes over the first 12 weeks of rehabilitation for incomplete traumatic spinal cord injury: the multicenter randomized Spinal Cord Injury Locomotor Trial. Neurorehabil. Neural Repair 21, 25-35.
37. Field-Fote, E.C., Lindley, S.D., and Sherman, A.L. (2005). Locomotor training approaches for individuals with spinal cord injury: a preliminary report of walking-related outcomes. J. Neurol. Phys. Ther. 29, 127-137.
38. Loubinoux, I., Tombari, D., Pariente, J., Gerdelat-Mas, A., Franceries, X., Cassol, E., Rascol, O., Pastor, J., and Chollet, F. (2005). Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer. NeuroImage 27, 299-313
39. Consortium for Spinal Cord Medicine. (2000). Outcomes following traumatic spinal cord injury: clinical practice guidelines for healthcare professionals. J. Spinal Cord Med. 23, 289-316.
40. Hornby, T.G, Schmit, B.D., and Theiss, R.D. (2006). Serotonergic modulation of motor function in humans incomplete spinal cord injury, in: Society for Neuroscience Abstracts: Atlanta, GA.
41. El Masry, W.S., Tsubo, M., Katoh, S., El Miligui, Y.H., and Khan, A. (1996). Validation of the American Spinal Injury Association (ASIA) motor score and the National Acute Spinal Cord Injury Study (NASCIS) motor score. Spine 21, 614-619.
42. Bohannon, R.W., and Smith, M.B. (1987). Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys. Ther. 67, 206-207.
43. Dittuno, P.L., and Ditunno, J.F., Jr. (2001). Walking Index for Spinal Cord Injury (WISCI II): scale revision. Spinal Cord 39, 654-656.
44. Gunja, N., Collins, M., and Graudins, A. (2004). A comparison of the pharmacokinetics of oral and sublingual cyproheptadine. J. Toxicol. Clin. Toxicol. 42, 79-83.
45. PDR Staff. (2011). Physicians' Desk Reference. 65th ed. PDR Network, LLC: Montvale, NJ
46. Lewek, M.D., Cruz, T.H., Moore, J.L., Roth, H.R., Dhaher, Y.Y., and Hornby, T.G. (2009). Allowing intralimb kinematic variability during locomotor training poststroke improves kinematic consistency: a subgroup analysis from a randomized clinical trial. Phys. Ther. 89, 829-839.
47. Field-Fote, E.C., and Tepavac, D. (2002). Improved intralimb coordination in people with incomplete spinal cord injury following training with body weight support and electrical stimulation. Phys. Ther. 82, 707-715.
48. Thompson, C.K., Jayaraman, A., Kinnaird, C, and Hornby, T.G (2011). Methods to quantify pharmacologically induced alterations in motor function in human incomplete SCI. J. Vis. Exp. Apr 18;(50). pii: 2148. doi: 10.3791/2148.
49. Pang, M.Y., and Yang, J.F. (2000). The initiation of the swing phase in human infant stepping: importance of hip position and leg loading. J. Physiol. 528, 389-404.
50. Clark, D.J., Ting, L.H., Zajac, F.E., Neptune, R.R., and Kautz, S.A. (2010). Merging of healthy motor modules predicts reduced locomotor performance and muscle coordination complexity post-stroke. J. Neurophysiol. 103, 844-857.
51. Neptune, R.R., Clark, D.J., and Kautz, S.A. (2009). Modular control of human walking: a simulation study. J. Biomech. 42, 1282-1287.
52. Hornby, T.G., Straube, D.S., Kinnaird, C.R., Holleran, C.L., Echauz, A.J., Rodriguez, K.S., Wagner, E.J., and Narducci, E.A. (2011). Importance of specificity, amount, and intensity of locomotor training to improve ambulatory function in patients poststroke. Top. Stroke Re-habil. 18, 293-307.
53. Chopek, J.W., MacDonell, C.W., Power, K.E., Gardiner, K., and Gardiner, P.F. (2013). Removal of supraspinal input reveals a difference in the flexor and extensor monosynaptic reflex response to qui-pazine independent of motoneuron excitation. J. Neurophysiol. 109, 2056-2063.
54. Barolat, G., and Maiman, D.J. (1987). Spasms in spinal cord injury: a study of 72 subjects. J. Am. Paraplegia Soc. 10, 35-39.
55. Wirz, M., Zemon, D.H., Rupp, R., Scheel, A., Colombo, G., Dietz, V., and Hornby, T.G. (2005). Effectiveness of automated locomotor training in patients with chronic incomplete spinal cord injury: a multicenter trial. Arch. Phys. Med. Rehabil. 86, 672-680.
56. Wirz, M., Colombo, G., and Dietz, V. (2001). Long term effects of locomotor training in spinal humans. J. Neurol. Neurosurg. Psychiatry 71, 93-96.
57. Wirz, M., van Hedel, H.J., Rupp, R., Curt, A., and Dietz, V. (2006). Muscle force and gait performance: relationships after spinal cord injury. Arch. Phys. Med. Rehabil. 87, 1218-1222.
58. Winchester, P., Smith, P., Foreman, N., Mosby, J.M., Pacheco, F., Querry, R., and Tansey, K. (2009). A prediction model for determining over ground walking speed after locomotor training in persons with motor incomplete spinal cord injury. J. Spinal Cord Med. 32, 63-71.
59. Loubinoux, I., Pariente, J., Boulanouar, K., Carel, C., Manelfe, C., Rascol, O., Celsis, P., and Chollet, F. (2002). A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects. Neuroimage 15, 26-36.
60. Zittel, S., Weiller, C., and Liepert, J. (2008). Citalopram improves dexterity in chronic stroke patients. Neurorehabil. Neural Repair 22, 311-314.
61. Dam, M., Tonin, P., De Boni, A., Pizzolato, G., Casson, S., Ermani, M., Freo, U., Piron, L., and Battistin, L. (1996). Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27, 1211-1214.
62. Pariente, J., Loubinoux, I., Carel, C., Albucher, J.F., Leger, A., Manelfe, C., Rascol, O., and Chollet, F. (2001). Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann. Neurol. 50, 718-729.
63. Chollet, F., Tardy, J., Albucher, J.F., Thalamas, C., Berard, E., Lamy, C., Bejot, Y., Deltour, S., Jaillard, A., Niclot, P., Guillon, B., Moulin, T., Marque, P., Pariente, J., Arnaud, C., and Loubinoux, I. (2011). Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 10, 123-130.